Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome. Issue 5 (28th September 2015)

• Record Type: Journal Article
• Authors: Vetro, Calogero; Rosso, Rosamaria; Palmucci, Stefano; Russello, Maurizio; Colletta, Grazia; Romeo, Maria Anna; Ximenes, Benedetta; Romano, Alessandra; Palumbo, Giuseppe Alberto; Di Raimondo, Francesco
• Is Part Of: Journal of clinical apheresis. Volume 31:Issue 5(2016)
• Page Start: 443
• Page End: 447
• Publication Date: 2015-09-28
• Subjects: iron overload -- metabolic syndrome X -- magnetic resonance imaging; Hemapheresis -- Periodicals; Blood -- Transfusion -- Periodicals; Blood -- Transfusion, Autologous -- Periodicals; Cell separation -- Periodicals; Leukapheresis -- Periodicals; Plasmapheresis -- Periodicals; 615.39
• DOI: 10.1002/jca.21434
• Languages: English
• ISSNs: 0733-2459

Abstract

Abstract : Dysmetabolic iron overload syndrome is a rare event causing hepatic impairment with serious long‐term side effects. Here, we describe a case of metabolic syndrome‐related hepatic iron overload that showed a rapid, effective, and safe response to erythrocytapheresis. J. Clin. Apheresis 31:443–447, 2016. © 2015 Wiley Periodicals, Inc.